Sudeep Pharma IPO Sees Strong Demand on Day One; Grey Market Premium Falls
Sudeep Pharma Ltd.’s initial public offer was oversubscribed on the first day, led by non-institutional and retail investors, with the grey market premium indicating a 19% upside from the issue price.